Home / Companies / Glenmark Pharmaceuticals Limited / 29 Sep 2023
Glenmark Pharmaceuticals Limited: meeting of 29 Sep 2023
Votes reported on Form N-PX, item by item
34 Form N-PX filers reported votes at the Glenmark Pharmaceuticals Limited meeting of 29 Sep 2023. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 61.1% of reported votes for; 26 filers withheld from or voted against at least one nominee.
90 vote records from 34 filers. 0 of the 34 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
5 vote records from 5 filers. 0 of the 5 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
45 vote records from 34 filers. 0 of the 34 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
40 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
82 vote records from 30 filers. 0 of the 30 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
8 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | No report |
| BlackRock and iShares | Split or no vote | No report |
| Fidelity | Split or no vote | No report |
| Dimensional | Split or no vote | No report |
| State Street and SPDR | Split or no vote | No report |
| American Century | Split or no vote | No report |
| Franklin Templeton | Split or no vote | No report |
| Invesco | For | No report |
| Charles Schwab | Split or no vote | For |
| Nuveen and TIAA | For | No report |
| John Hancock and Manulife | Split or no vote | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | No report |
| J.P. Morgan | Split or no vote | For |
| WisdomTree | Split or no vote | No report |
| Northern Trust and FlexShares | Split or no vote | No report |
| Brighthouse Funds | Split or no vote | No report |
| Capital Group and American Funds | For | No report |
| PIMCO | Split or no vote | No report |
| Macquarie and Delaware Funds | Split or no vote | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Glenmark Pharmaceuticals Limited meeting?
34 Form N-PX filers reported votes at the meeting of 29 Sep 2023. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Glenmark Pharmaceuticals Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Glenmark Pharmaceuticals Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Glenmark Pharmaceuticals Limited with a meeting date within three days of 29 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.